鼻牙槽塑形唇裂方案:从出生到面部成熟的长期治疗结局
单中心回顾1990至2000年接受鼻牙槽塑形(NAM)的唇裂患者107例(单侧69例、双侧38例),分析手术与正畸结局。头影测量显示上颌位置与面部比例无显著差异,提示NAM联合龈骨膜成形术可能不阻碍面中部生长。
要点
- NAM联合龈骨膜成形术后57%患者免于牙槽骨移植
- 单侧唇裂患者上颌位置与面部比例未见显著统计学差异
核心结论
- NAM方案在从出生到面部成熟期间软组织修整与牙槽骨移植率低,且每例患者总手术次数少。
- 接受龈骨膜成形术与NAM的单侧唇裂患者面部成熟时头影测量提示该方案可能不阻碍面中部生长。
研究设计与样本
- 单机构回顾性研究,纳入1990至2000年间接受鼻牙槽塑形的唇裂患者,最终107例符合标准(单侧69例、双侧38例)。
- 末次随访平均年龄20岁(范围15岁4个月至26岁10个月)。
主要发现
- 龈骨膜成形术患者中57%(52/91)无需牙槽骨移植(单侧59%,32/54;双侧54%,20/37)。
- 19%(20/107)无需修整手术、牙槽骨移植或正颌手术(单侧20%,14/69;双侧16%,6/38)。
- 单侧唇裂患者头影测量上颌位置或面部比例无显著统计学差异。
临床怎么用
- 对唇裂患儿可考虑NAM联合龈骨膜成形术,以期降低牙槽骨移植与软组织修整需求。
- 长期随访需关注面中部生长,本方案未显示显著阻碍面中部生长的证据。
局限性
- 为单机构回顾性研究,证据等级为治疗性IV级。
- 头影测量分析仅覆盖单侧唇裂患者,双侧患者缺乏相应生长分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The authors present outcomes analysis of the nasoalveolar molding treatment protocol in patients with a cleft followed from birth to facial maturity. METHODS: A single-institution retrospective review was conducted of cleft patients who underwent nasoalveolar molding between 1990 and 2000. Collected data included surgical and orthodontic outcomes and incidence of gingivoperiosteoplasty, alveolar bone grafting, surgery for velopharyngeal insufficiency, palatal fistula repair, orthognathic surgery, nose and/or lip revision, and facial growth. RESULTS: One hundred seven patients met inclusion criteria (69 with unilateral and 38 with bilateral cleft lip and palate). Eighty-five percent (91 of 107) underwent gingivoperiosteoplasty (unilateral: 78 percent, 54 of 69; bilateral: 97 percent, 37 of 38). Of those patients, 57 percent (52 of 91) did not require alveolar bone grafting (unilateral: 59 percent, 32 of 54; bilateral: 54 percent, 20 of 37). Twelve percent (13 of 107) of all study patients underwent revision surgery to the lip and/or nose before facial maturity (unilateral: 9 percent, six of 69; bilateral: 18 percent, seven of 38). Nineteen percent (20 of 107) did not require a revision surgery, alveolar bone grafting, or orthognathic surgery (unilateral: 20 percent, 14 of 69; bilateral: 16 percent, six of 38). Cephalometric analysis was performed on all patients with unilateral cleft lip and palate. No significant statistical difference was found in maxillary position or facial proportion. Average age at last follow-up was 20 years (range, 15 years 4 months to 26 years 10 months). CONCLUSIONS: Nasoalveolar molding demonstrates a low rate of soft-tissue revision and alveolar bone grafting, and a low number of total operations per patient from birth to facial maturity. Facial growth analysis at facial maturity in patients who underwent gingivoperiosteoplasty and nasoalveolar molding suggests that this proposal may not hinder midface growth. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
引用
- Yarholar LM, Shen C, Wangsrimongkol B, et al. The Nasoalveolar Molding Cleft Protocol: Long-Term Treatment Outcomes from Birth to Facial Maturity. Plast Reconstr Surg. 2021. PMID: 33890899. doi:10.1097/PRS.0000000000007828
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。